Internal Medicine Doctors in Ft. Benning, GA Accepting Medicare
1 Internal Medicine doctors found. Showing 1 - 1
 Dr. Christina Marie Stavitski, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7950 Martin Loop, Martin Army Community Hospital, Ft. Benning, GA 31905 Phone: 706-544-1245 |
News Archive
Escherichia coli cases drop in 2009
As per a report from the Centers for Disease Control and Prevention (CDC) a 12 % drop in rates of Escherichia coli (E.coli) infection has been noted in 2009 as compared to statistics for 2008. This is being seen by federal health officials as a sign that the new food safety measures are effective. Most of the pathogens under study are from the bacteria family like E.coli 0157, salmonella, campylobacter, listeria and vibrio. It was found that food poisoning rates for the most common pathogens have changed little from statistics collected in 2004.
3D image of cell signaling molecules indicates a trippable power switch
A three-dimensional image of one of the proteins that serves as an on-off switch as it binds to receptors on the surface of a cell suggests there may be a sort of main power switch that could be tripped. These surface receptors are responsible for helping cells discern light, set the heart racing, or detect pain.
Microbes in maternal intestine may contribute to metabolic changes during pregnancy
New research in The Journal of Physiology has found, using a mouse model, that microbes in the maternal intestine may contribute to impairment of the gut barrier during pregnancy.
Washington Post buys major stake in Celtic Healthcare Inc.; Tenet plans buybacks
Post Co. said Monday it would buy a majority stake in Celtic Healthcare Inc., a closely held provider of hospice and home health care in Pennsylvania and Maryland. Terms of the deal weren't disclosed, although one analyst, Sheryl Skolnick of CRT Capital Group, said average valuations suggests the deal could have been worth at least $50 million. That is a drop in the bucket for Post Co., which has a market capitalization of $2.7 billion.
Provectus PV-10 Phase 2 trial data on metastatic melanoma to be presented at two conferences
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 PV-10 metastatic melanoma study will be presented at two upcoming melanoma conferences.
› Verified 4 days ago